Hepatic steatosis and lactic acidosis caused by stavudine in an HIV-infected patient

被引:19
作者
Bleeker-Rovers, CP [1 ]
Kadir, SW [1 ]
van Leusen, R [1 ]
Richter, C [1 ]
机构
[1] Rijnstate Hosp, Dept Internal Med, Arnhem, Netherlands
关键词
stavudine; hepatic steatosis; lactic acidosis; mitochondrial toxicity;
D O I
10.1016/S0300-2977(00)00064-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lactic acidosis and hepatic steatosis caused by mitochondrial toxicity of nucleoside reverse transcriptase inhibitors (NRTI) is a rare cause of liver disease with a high mortality rate. This report describes a male, HIV-positive patient with a 4-week history of nausea, vomiting and abdominal pain. His medication consisted of prednisone 5 mg od (because of auto-immune thrombocytopenia), didanosine (for 2 years) and stavudine (for 3 months). Laboratory studies showed cholestasis and elevation of aminotransferases. Lactic level was not measured. Liver biopsy revealed steatosis and cholestatic hepatitis. In the absence of other causes of liver disease a probable diagnosis of stavudine-induced hepatic toxicity was made. After discontinuation of NRTI, he recovered completely. Because lactic acidosis had nor been confirmed, stavudine was restarted and within 1 week the lactate level increased significantly. Therefore stavudine was discontinued again. One year later the patient is doing well on a double protease inhibitor regimen. In conclusion, clinicians treating patients with NRTI should be aware of the risk of lactic acidosis and hepatic steatosis. When this is suspected, all NRTI must be stopped. The diagnosis can be made when elevated lactate levels and hepatic steatosis are present in the absence of other causes of liver disease. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:190 / 193
页数:4
相关论文
共 15 条
  • [1] FULMINANT-HEPATITIS WITH SEVERE LACTATE ACIDOSIS IN HIV-INFECTED PATIENTS ON DIDANOSINE THERAPY
    BISSUEL, F
    BRUNEEL, F
    HABERSETZER, F
    CHASSARD, D
    COTTE, L
    CHEVALLIER, M
    BERNUAU, J
    LUCET, JC
    TREPO, C
    [J]. JOURNAL OF INTERNAL MEDICINE, 1994, 235 (04) : 367 - 371
  • [2] Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway
    Brinkman, K
    ter Hofstede, HJM
    Burger, DM
    Smeitinkt, JAM
    Koopmans, PP
    [J]. AIDS, 1998, 12 (14) : 1735 - 1744
  • [3] BRINKMAN K, 1998, 12 WORLD AIDS C GEN
  • [4] CHEN CH, 1991, MOL PHARMACOL, V39, P625
  • [5] Mitochondrial medicine
    Chinnery, PF
    Turnbull, DM
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 1997, 90 (11) : 657 - 667
  • [6] FORTGANG IS, 1995, AM J GASTROENTEROL, V90, P1433
  • [7] HEPATOMEGALY WITH SEVERE STEATOSIS IN HIV-SEROPOSITIVE PATIENTS
    FREIMAN, JP
    HELFERT, KE
    HAMRELL, MR
    STEIN, DS
    [J]. AIDS, 1993, 7 (03) : 379 - 385
  • [8] INHIBITION OF MITOCHONDRIAL BETA-OXIDATION AS A MECHANISM OF HEPATOTOXICITY
    FROMENTY, B
    PESSAYRE, D
    [J]. PHARMACOLOGY & THERAPEUTICS, 1995, 67 (01) : 101 - 154
  • [9] JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
  • [10] Hepatic steatosis and lactic acidosis associated with stavudine treatment in an HIV patient: A case report
    Lenzo, NP
    Garas, BA
    French, MA
    [J]. AIDS, 1997, 11 (10) : 1294 - 1296